Cargando…
The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment
Ovarian cancer is the deadliest gynecological disease among U.S. women. Poor 5-year survival rates (<30%) are due to presentation of most women at diagnosis with advanced stage disease with widely disseminated intraperitoneal metastasis. However, when diagnosed before metastatic propagation the o...
Autor principal: | Hilliard, Tyvette S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162689/ https://www.ncbi.nlm.nih.gov/pubmed/30134520 http://dx.doi.org/10.3390/cancers10090277 |
Ejemplares similares
-
Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment
por: Hilliard, Tyvette S., et al.
Publicado: (2021) -
Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
por: Zhang, Xianyu, et al.
Publicado: (2022) -
Targeting mesothelin in ovarian cancer
por: Ghafoor, Azam, et al.
Publicado: (2018) -
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
por: Yu, Yi, et al.
Publicado: (2011) -
Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy
por: Liu, Yueying, et al.
Publicado: (2023)